Innovent Biologics Inc 1801.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 4:08 PM CTT
38.25quote price arrow down-1.50 (-3.77%)
Volume
8,629,492
52 week range
27.30 - 49.80
Loading...
  • Open39.50
  • Day High40.40
  • Day Low38.00
  • Prev Close39.75
  • 52 Week High49.80
  • 52 Week High Date11/06/23
  • 52 Week Low27.30
  • 52 Week Low Date08/08/23

Key Stats

  • Market Cap8,114.44M
  • Shares Out1,622.68M
  • 10 Day Average Volume7.74M
  • Dividend-
  • Dividend Yield-
  • Beta0.7
  • YTD % Change-10.53

KEY STATS

  • Open39.50
  • Day High40.40
  • Day Low38.00
  • Prev Close39.75
  • 52 Week High49.80
  • 52 Week High Date11/06/23
  • 52 Week Low27.30
  • 52 Week Low Date08/08/23
  • Market Cap8,114.44M
  • Shares Out1,622.68M
  • 10 Day Average Volume7.74M
  • Dividend-
  • Dividend Yield-
  • Beta0.7
  • YTD % Change-10.53

RATIOS/PROFITABILITY

  • EPS (TTM)-0.72
  • P/E (TTM)-53.35
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Innovent Biologics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Innovent Biologics Inc is an investment holding company principally engaged in biopharmaceuticals. The Company and its subsidiaries are engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical products, and provision of consultation and research and development services. The Company's main product is Tyvyt (sintilimab injection), which is used to treat relapsed or refractory classical Hodgkin’s lymphoma. The...
De-Chao Yu Ph.D.
Executive Chairman of the Board, Chief Executive Officer
You Fei
Chief Financial Officer
Address
168
Dongping Street, Suzhou Industrial Park
Suzhou, JNG
215123
China